术前心力衰竭治疗可预防较低风险患者术后心脏并发症:回顾性队列研究
该回顾性队列分析基于130,677例非心脏手术患者的医院登记数据,其中心力衰竭病史者10,256例(7.9%)。心力衰竭病史与术后30天心脏并发症风险升高相关(8.1% vs 1.1%;校正OR 2.28,95%CI 2.02-2.56;P<0.001)。较低风险的心力衰竭患者术前接受抗心衰药物治疗的比例较低,但预防性治疗可显著降低其术后心脏并发症风险。
要点
- 心力衰竭病史使非心脏手术后30天心脏并发症风险增加约2倍。
- 较低风险心衰患者术前抗心衰药物使用率更低,但预防性治疗可降低并发症风险。
- 应重视较低风险心衰患者的术前优化治疗,而非仅关注高风险者。
核心结论
- 在术前风险较低的的心力衰竭患者中,临床医生常未充分进行术前优化。
- 术前预防性治疗可降低这些较低风险心衰患者术后心脏并发症风险。
研究设计与样本
- 回顾性队列研究,分析130,677例非心脏手术患者的医院登记数据。
- 暴露为术前心力衰竭病史,主要结局为术后30天内心肌梗死、心脏骤停、急性心衰和死亡的复合终点。
主要发现
- 心衰病史患者术后心脏并发症发生率为8.1%,无心衰病史者为1.1%。
- 校正后OR为2.28(95%CI 2.02-2.56),P<0.001。
- 较低风险心衰患者归因于心衰的术后心脏并发症校正绝对风险差为1.7%(95%CI 1.4%-2.0%),较高风险者为0.5%(95%CI -0.6%至1.6%),组间P=0.38。
- 较低风险心衰患者术前接受抗心衰药物的比例分别为59% vs 72%和61% vs 82%(均P<0.001)。
临床怎么用
- 对合并心力衰竭的非心脏手术患者,应评估术前抗心衰治疗是否充分。
- 即使术前风险较低,也需关注心衰患者的术前优化,以降低术后心脏并发症风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The objective of this study was to identify undertreated subgroups of patients with heart failure who would benefit from better perioperative optimization. SUMMARY OF BACKGROUND DATA: Patients with heart failure have increased risks of postoperative cardiac complications after noncardiac surgery. METHODS: In this analysis of hospital registry data of 130,677 patients undergoing noncardiac surgery, the exposure was preoperative history of heart failure. The outcome, cardiac complications, was defined as a composite of myocardial infarction, cardiac arrest, acute heart failure, and mortality within 30 postoperative days. RESULTS: History of heart failure (n = 10,256; 7.9%) was associated with increased risk of cardiac complications [8.1% vs 1.1%; adjusted odds ratio, 2.28 (95% CI, 2.02-2.56); P < 0.001). Patients with heart failure and who carried a lower risk profile had increased risks of postoperative cardiac complications secondary to heart failure [adjusted absolute risk difference, 1.7% (95% CI, 1.4%-2.0%, lower risk); P < 0.001 vs 0.5% (95% CI, -0.6% to 1.6%, higher risk); P = 0.38]. Patients with heart failure and lower risk received a lower level of health care utilization preoperatively, and less frequently received anti-heart failure medications (59% vs 72% and 61% vs 82%; both P < 0.001). These preventive therapies significantly decreased the risk of cardiac complications in patients with heart failure. CONCLUSIONS: In patients with heart failure who have a lower preoperative risk profile, clinicians often make insufficient attempts to optimize their clinical condition preoperatively. Preoperative preventive treatment reduces the risk of postoperative cardiac complications in these lower-risk patients with heart failure.
引用
- Shay D, Ng PY, Dudzinski DM, et al. Preoperative Heart Failure Treatment Prevents Postoperative Cardiac Complications in Patients With Lower Risk: A Retrospective Cohort Study. Ann Surg. 2021. PMID: 33534230. doi:10.1097/SLA.0000000000004779
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。